Liver Institute Northwest
Kris V. Kowdley MD
We are now offering Telemedicine Consultations
In light of the impact of the COVID-19 pandemic, Liver Institute Northwest is now offering audio & video telemedicine consultations with Dr. Kowdley for patients with liver disorders. Requests for appointments can be submitted online and we will contact you to schedule your virtual visit. Please click the button below and follow the instructions to set up a telemedicine appointment on our user friendly platform offering secure HIPAA compliant communication.
New Liver News
Kowdley KV, Vuppalanchi R, Levy C, Floreani A, Andreone P, LaRusso NF, Shrestha R, Trotter J, Goldberg D, Rushbrook S, Hirschfield GM, Schiano T, Jin Y, Pencek R, MacConell L, Shapiro D, Bowlus CL; AESOP Study Investigators. J Hepatol. 2020 Mar 10:S0168-8278(20)30160-4. doi: 10.1016/j.jhep.2020.02.033. Online ahead of print. PMID: 32165251 Free article.
This was a randomized double blind placebo controlled trial of doses of obeticholic acid (OCA) for PSC. There was a significant improvement in the alkaline phosphatase level in OCA- treated patients; the major side effect was dose-related itching with treatment.
We are currently focused on clinical trials in fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hereditary hemochromatosis and chronic hepatitis B. If you are interested in participating in a clinical trial, please contact us.